Mohamedilias Jimidar

Title: Innovations of Mohamedilias Jimidar in Esketamine Formulations

Introduction

Mohamedilias Jimidar is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of esketamine formulations. His work focuses on enhancing the stability and efficacy of pharmaceutical compositions.

Latest Patents

Jimidar holds a patent for "Esketamine formulations and methods for preparation and storage." This patent discloses pharmaceutical compositions that include esketamine or a pharmaceutically acceptable salt thereof, along with an oxidative degradant. Notably, the oxidative degradant can be 6-(2-chlorophenyl)-6-oxohexanoic acid or a pharmaceutically acceptable salt thereof. The patent also outlines methods for limiting the formation of oxidative degradants in these compositions.

Career Highlights

Jimidar is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions that address critical challenges in drug formulation and stability.

Collaborations

Some of his notable coworkers include Caroline Anne Aerts and Kris Kayens. Their collaborative efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Mohamedilias Jimidar's contributions to esketamine formulations exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances the stability of medications but also paves the way for future advancements in drug formulation.